ArticleOncology letters2019

Silencing of LIMD1 promotes proliferation and reverses cell adhesion-mediated drug resistance in non-Hodgkin's lymphoma.

Jie Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.